Efficacy of Rapid Postpartum Treatment

Leslie Morrow, Ph.D.

UNC Department of Psychiatry

Distinguished Professor
Professor, UNC Department of Pharmacology

Researchers at the UNC Center for Women’s Mood Disorders are studying the effectiveness of the neurosteroid brexanolone, a rapid treatment for postpartum depression (PPD), a debilitating mental illness impacting at least 10-15% of women who give birth.

Brexanolone is the first FDA-approved pharmacotherapy specifically developed and approved to treat PPD and relieve suffering within days.

Ongoing studies surrounding its effectiveness may provide a better understanding of postpartum depression itself.